Quality of life and related demographic factors in long-term survivors of childhood non-Hodgkin's lymphoma
HU Yang, WU Liu-Hong, GUAN Hui-Jie, WU Su-Yun, LIU Long-Zhen, CAI Rui-Qing, XU Yan-Jie, ZHANG Yi-Zhuo, SUN Xiao-Fei, ZHU Jia
Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China (Zhu J, Email: zhujia@sysucc.org.cn)
Abstract Objective To evaluate the quality of life and related demographic factors in long-term survivors of childhood non-Hodgkin's lymphoma (NHL). Methods A retrospective analysis was performed on the medical and demographic data of the NHL patients who received treatment in the Sun Yat-sen University Cancer Center and achieved long-term survival at follow-up, with an age of <18 years at initial diagnosis and a present age of ≥18 years. A questionnaire survey was performed using 36-Item Short-Form Health Survey (SF-36) and the symptom subscale of the Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (QLQ-C30). The health status of long-term survivors of NHL was evaluated by comparing the scores of various dimensions of the SF-36 scale of general adult population in the United States (American norm) and those of the SF-36 scale of general adult population in Hong Kong, China (Hong Kong norm). The correlation between the score of each dimension of the scale and demographic characteristics was evaluated. The symptoms of long-term NHL survivors were evaluated according to the score of QLQ-C30 scale. Results A total of 23 patients with NHL with complete follow-up data were enrolled. The pathological types included diffuse large B-cell lymphoma in 10 patients, Burkitt lymphoma in 4 patients, T-cell lymphoblastoma in 5 patients, B-cell lymphoblastoma in 3 patients, and natural killer/T cell lymphoma in 1 patient. All patients received the chemotherapy regimen containing anthracyclines and alkylating agents. The median present age was 26.2 years (range: 16.9-55.8 years), and the median age at initial diagnosis was 10.4 years (range: 2.4-17.6 years). Among the 23 patients, 6 were married and had children and 2 had chronic diseases. There was no significant difference between the long-term survivors and the US norm in role physical, general health, role-emotional, and mental health (P>0.05), while the long-term survivors had significantly better scores of the other dimensions than the US norm (P<0.05). Similar results were obtained for the comparison between the long-term survivors and the China Hong Kong norm. Age at initial diagnosis was negatively correlated with the scores of social functioning, role physical, and general health in the SF-36 scale (P<0.05), and the present age of patients was positively correlated with the score of physical functioning and was negatively correlated with the score of general health (P<0.05). The urban and rural distribution of patients was related to the general health status (P<0.05). In addition, the long-term survivors of childhood NHL had relatively low scores of the symptom domain of QLQ-C30, and few moderate or severe symptoms were found. Conclusions Long-term survivors of childhood NHL tend to have a good overall health status, with no significant differences compared with the general population. Age at initial diagnosis is the main demographic factor that affects patients' quality of life. Citation:
HU Yang,WU Liu-Hong,GUAN Hui-Jie et al. Quality of life and related demographic factors in long-term survivors of childhood non-Hodgkin's lymphoma[J]. CJCP, 2021, 23(9): 882-888.
HU Yang,WU Liu-Hong,GUAN Hui-Jie et al. Quality of life and related demographic factors in long-term survivors of childhood non-Hodgkin's lymphoma[J]. CJCP, 2021, 23(9): 882-888.
Harju E, Roser K, Dehler S, et al. Health-related quality of life in adolescent and young adult cancer survivors[J]. Support Care Cancer, 2018, 26(9): 3099-3110. PMID: 29572734. DOI: 10.1007/s00520-018-4151-z.
Gibson TM, Mostoufi-Moab S, Stratton KL, et al. Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort[J]. Lancet Oncol, 2018, 19(12): 1590-1601. PMID: 30416076. DOI: 10.1016/S1470-2045(18)30537-0.
Krull KR, Hardy KK, Kahalley LS, et al. Neurocognitive outcomes and interventions in long-term survivors of childhood cancer[J]. J Clin Oncol, 2018, 36(21): 2181-2189. PMID: 29874137. DOI: 10.1200/JCO.2017.76.4696.
Lin YW, Yu YL, Zeng JY, et al. Comparing the reliability and validity of the SF-36 and SF-12 in measuring quality of life among adolescents in China: a large sample cross-sectional study[J]. Health Qual Life Outcomes, 2020, 18(1): 360. PMID: 33168020. DOI: 10.1186/s12955-020-01605-8.
J?rng?rden A, Wettergen L, von Essen L. Measuring health-related quality of life in adolescents and young adults: Swedish normative data for the SF-36 and the HADS, and the influence of age, gender, and method of administration[J]. Health Qual Life Outcomes, 2006, 4: 91. PMID: 17140436. PMCID: PMC1697805. DOI: 10.1186/1477-7525-4-91.
Nolte S, Liegl G, Petersen MA, et al. General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States[J]. Eur J Cancer, 2019, 107: 153-163. PMID: 30576971. DOI: 10.1016/j.ejca.2018.11.024.
Ware JEJ, Gandek B. Overview of the SF-36 health survey and the international quality of life assessment (IQOLA) project[J]. J Clin Epidemiol, 1998, 51(11): 903-912. PMID: 9817107. DOI: 10.1016/s0895-4356(98)00081-x.
Lam CLK, Tse EYY, Gandek B, et al. The SF-36 summary scales were valid, reliable, and equivalent in a Chinese population[J]. J Clin Epidemiol, 2005, 58(8): 815-822. PMID: 16018917. DOI: 10.1016/j.jclinepi.2004.12.008.
Egan G, Goldman S, Alexander S. Mature B-NHL in children, adolescents and young adults: current therapeutic approach and emerging treatment strategies[J]. Br J Haematol, 2019, 185(6): 1071-1085. PMID: 30613948. DOI: 10.1111/bjh.15734.
Langer T, Grabow D, Steinmann D, et al. Late effects and long-term follow-up after cancer in childhood[J]. Oncol Res Treat, 2017, 40(12): 746-750. PMID: 29183026. DOI: 10.1159/000484936.
Maunsell E, Pogany L, Barrera M, et al. Quality of life among long-term adolescent and adult survivors of childhood cancer[J]. J Clin Oncol, 2006, 24(16): 2527-2535. PMID: 16735705. DOI: 10.1200/JCO.2005.03.9297.
Ehrhardt MJ, Sandlund JT, Zhang N, et al. Late outcomes of adult survivors of childhood non-hodgkin lymphoma: a report from the St. Jude Lifetime Cohort Study[J]. Pediatr Blood Cancer, 2017, 64(6): e26338. PMID: 27860222. DOI: 10.1002/pbc.26338.
Ehrhardt MJ, Mulrooney DA, Li CH, et al. Neurocognitive, psychosocial, and quality-of-life outcomes in adult survivors of childhood non-Hodgkin lymphoma[J]. Cancer, 2018, 124(2): 417-425. PMID: 28915338. DOI: 10.1002/cncr.31019.
Henchoz Y, Büla C, Guessous I, et al. Association between physical frailty and quality of life in a representative sample of community-dwelling Swiss older people[J]. J Nutr Health Aging, 2017, 21(5): 585-592. PMID: 28448091. DOI: 10.1007/s12603-016-0772-4.
Green DM, Liu W, Kutteh WH, et al. Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study[J]. Lancet Oncol, 2014, 15(11): 1215-1223. PMID: 25239573. DOI: 10.1016/S1470-2045(14)70408-5.
Chow EJ, Stratton KL, Leisenring WM, et al. Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the Childhood Cancer Survivor Study cohort[J]. Lancet Oncol, 2016, 17(5): 567-576. PMID: 27020005. DOI: 10.1016/S1470-2045(16)00086-3.
Br?mswig JH, Riepenhausen M, Schellong G. Parenthood in adult female survivors treated for Hodgkin's lymphoma during childhood and adolescence: a prospective, longitudinal study[J]. Lancet Oncol, 2015, 16(6): 667-675. PMID: 25959806. DOI: 10.1016/S1470-2045(15)70140-3.
Keegan THM, Bleyer A, Rosenberg AS, et al. Second primary malignant neoplasms and survival in adolescent and young adult cancer survivors[J]. JAMA Oncol, 2017, 3(11): 1554-1557. PMID: 28426850. DOI: 10.1001/jamaoncol.2017.0465.
Bluhm EC, Ronckers C, Hayashi RJ, et al. Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study[J]. Blood, 2008, 111(8): 4014-4021. PMID: 18258798. DOI: 10.1182/blood-2007-08-106021.
Hudson MM, Ness KK, Gurney JG, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer[J]. JAMA, 2013, 309(22): 2371-2381. PMID: 23757085. DOI: 10.1001/jama.2013.6296.
Burkhardt B, Zimmermann M, Oschlies I, et al. The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence[J]. Br J Haematol, 2005, 131(1): 39-49. PMID: 16173961. DOI: 10.1111/j.1365-2141.2005.05735.x.
WANG Hui-Min, LIU Chuan-He, LIU Chang-Shan, WANG Ying, HAN Zhi-Ying, SUN Xin, CHEN Xing, AN Shu-Hua, DUOLIKUN Muzhapaer, LU Ai-Ping, WANG Min, CHENG Yan, YIN Xiao-Mei, LIU Han-Min, WANG Hong, HUA Shan, DONG Li, HUANG Ying, JIANG Yi, XIONG Jian-Xin, DING Sheng-Gang, ZHAO Shun-Ying, WANG Jin-Rong, HUANG Gui-Min, MU Jing-Hui, CHEN Yu-Zhi. Efficacy of Huaiqihuang granules as adjuvant therapy for bronchial asthma in children: a real-world study[J]. CJCP, 2021, 23(9): 877-881.
